, Tracking Stock Market Picks
Enter Symbol:
Adolor Corporation (ADLR) [hlAlert]

up 16.05 %

Adolor Corporation (ADLR) rated Outperform by Cowen & Co

Posted on: Monday,  Feb 11, 2008  9:25 AM ET by Cowen & Co

Cowen & Co rated Outperform Adolor Corporation (NASDAQ: ADLR) on 02/11/2008, when the stock price was $4.11. Since
then, Adolor Corporation has gained 16.06% as of 12/09/2011's recent price of $4.77.
If you would have followed this Cowen & Co's recommendation on ADLR, you would have gained 16.05% of your investment in 1397 days.

Adolor Corporation is a biopharmaceutical company. The Company has specialized in the discovery and development of prescription pain management products. It has a number of product candidates in various stages of development, ranging from preclinical studies to pivotal clinical trials. On May 20, 2008, the United States Food and Drug Administration (FDA) approved the Company?s first product, ENTEREG (alvimopan), for the management of postoperative ileus following bowel resection surgery (POI). ENTEREG is specifically indicated to accelerate the time to upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis. The Company in collaboration with Glaxo Group Limited (Glaxo), launched ENTEREG in the United States in mid-2008.

Cowen and Company’s culture is rooted in the traditions of the research boutiques that once dominated the investment research landscape. Our primary focus is on two products: 1. Proprietary information flow, and 2. Good investment ideas We achieve the first objective with a combination of extensive primary research work, organized survey activity, and access to industry experts (i.e., opinion leaders in medicine, technology, and consumer industries). We believe that the best investment idea is a “Correct Non-Consensus Conclusion,” and a considerable amount of our energy is devoted to this pursuit. We spend as little time as possible on traditional maintenance research products.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/11/2008 9:25 AM Buy
as of 12/24/2008
1 Week down  -0.91 %
1 Month up  1.40 %
3 Months up  15.50 %
1 YTD up  30.12 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy